Position in ARWR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$850,475
-$1,124,449 QoQ
Shares Held
10,434
-66.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#254
of 497 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. ARWR ranks #30 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $850,475 | 10,434 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,974,924 | 31,498 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,114,853 | 31,855 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $964,271 | 27,958 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $508,380 | 32,176 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $432,229 | 33,927 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $852,204 | 45,330 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $684,245 | 35,325 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $755,815 | 29,081 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,017,931 | 35,592 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $895,080 | 29,251 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $697,088 | 25,943 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $944,847 | 26,496 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $1,222,681 | 30,145 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $916,179 | 27,721 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $962,535 | 27,337 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,869,861 | 40,658 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,241,672 | 48,894 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,804,542 | 44,923 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,377,948 | 52,861 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,297,662 | 49,731 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,540,552 | 46,143 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,536,897 | 35,692 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,582,438 | 36,639 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $653,366 | 22,710 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||